Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

In our daily lives, we usually take our eyesight for granted and avoid going to see a professional regularly. Our eyesight is one of the most valuable assets that we have. There are hundreds of different eye diseases and conditions.…

Infectious keratitis is a critical eye condition that demands prompt attention and understanding. This article will delve into the intricacies of infectious keratitis, exploring its causes, treatment options, and preventive measures. Infectious keratitis is an inflammation of the cornea, the…

Brill Engines, a subsidiary of Brill Pharma, specializing in pioneering medical solutions for ophthalmology, announced the FDA approval of its groundbreaking medical device, the Corneal Esthesiometer Brill (CEB). This approval marks a significant milestone in the field of ophthalmology, as…

Oculus has unveiled the Pentacam Cornea OCT, an innovative device that integrates Scheimpflug imaging with the world’s first pericentric OCT scanning system. This dual imaging technology captures both Scheimpflug and ultra high-resolution OCT images of the cornea in just one…

The 42nd of the European Society of Cataract and Refractive Surgeons (ESCRS) is poised to offer a dynamic array of events and initiatives in 2024, featuring a mix of educational programs, commemorative milestones, and new insights into key areas of…

Bausch + Lomb recently published the results of a pivotal clinical trial for its TENEO™ Excimer Laser in the Journal of Refractive Surgery. This study, which played a crucial role in securing U.S. FDA approval for the device in January…

In a study published in the Journal of Proteome Research, researchers from Oregon Health & Science University (OHSU) have identified a connection between specific proteins found in patients’ tears and persistent pain experienced months after eye surgery. This discovery could…

Okyo Pharma announced its plan to initiate a phase 2 clinical trial for OK-101 in the treatment of neuropathic corneal pain (NCP), scheduled to begin in the third quarter of 2024. This one-year study follows promising results from preclinical animal…

What Is Symblepharon? Symblepharon is a medical condition characterized by the adhesion of the conjunctiva, the clear membrane that covers the white part of the eye and the inside of the eyelids, to the cornea, the clear front part of…

The 40th Congress of the ESCRS is taking place from 16-20 September 2022, at the Milano Convention Centre in Milan, Italy. The congress, which will host around 1,000 registered participants, will also be streamed via the virtual conferencing platform now…